Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Publication year range
1.
J Fr Ophtalmol ; 44(7): 977-980, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34147273

ABSTRACT

PURPOSE: To describe the management of an iris stromal cyst by fine needle aspiration and irrigation with absolute alcohol to induce cyst sclerosis. METHODS: We present the case of a 45-year-old patient with no previous history referred for a 3-month history of an iris lesion in his right eye. Examination revealed a 2.1×3mm cyst with transparent walls at the right inferonasal iris root, and a primary acquired iris stromal cyst was diagnosed. Initially, observation was recommended, but at the 2-month follow-up, growth of the lesion was observed, so fine needle aspiration and cryotherapy were performed, with recurrence after 2 months. Subsequently, fine needle aspiration and irrigation with absolute alcohol for 2minutes to induce sclerosis of the cyst was carried out. Two weeks after surgery, argon laser was performed on the iris root and remaining walls of the cyst to induce adherence. RESULTS: After 1 year of the procedure, the patient remains asymptomatic, without associated complications. A depression and hyperpigmentation of the iris in the inferonasal sector persists, without recurrence of internal fluid or increase in cyst volume. Endothelial cell count and intraocular pressure monitoring have remained stable. CONCLUSION: Iris stromal cyst sclerosis by aspiration and irrigation with absolute alcohol was effective and avoided complications associated with resection of the lesion.


Subject(s)
Cysts , Iris Diseases , Argon , Biopsy, Fine-Needle , Cysts/etiology , Cysts/surgery , Ethanol , Humans , Iris/pathology , Iris Diseases/diagnosis , Iris Diseases/etiology , Iris Diseases/therapy , Laser Coagulation , Lasers , Middle Aged , Neoplasm Recurrence, Local , Sclerosis
2.
Arch Soc Esp Oftalmol ; 82(6): 377-80, 2007 Jun.
Article in Spanish | MEDLINE | ID: mdl-17573650

ABSTRACT

OBJECTIVE: To ascertain the efficacy of idebenone and multivitamin treatment in Leber's hereditary optic neuropathy (LHON). METHOD: Two patients diagnosed of unilateral LHON were treated with megadoses of idebenone, vitamin C and riboflavin for one year. They were examined clinically before, during and after treatment. RESULTS: No improvement of visual function was observed. Despite the idebenone treatment, in both cases the second eye became involved. CONCLUSIONS: Despite previous reports of visual recovery with idebenone in patients with LHON, our experience shows that an effective treatment for Leber's disease remains to be found.


Subject(s)
Antioxidants/therapeutic use , Ascorbic Acid/therapeutic use , Benzoquinones/therapeutic use , Optic Atrophy, Hereditary, Leber/drug therapy , Riboflavin/therapeutic use , Vitamin B Complex/therapeutic use , Vitamins/therapeutic use , Adult , Female , Humans , Male , Treatment Failure , Ubiquinone/analogs & derivatives
3.
Arch. Soc. Esp. Oftalmol ; 82(6): 377-380, jun. 2007. ilus
Article in Es | IBECS | ID: ibc-055424

ABSTRACT

Objetivo: Determinar la eficacia del tratamiento con idebenona y multivitamínico en la neuropatía óptica hereditaria de Leber (NOHL). Método: Dos pacientes diagnosticados de NOHL, fueron tratados con idebenona, vitamina C y riboflavina durante un año. Ambos fueron evaluados clínicamente antes, durante y después del tratamiento. Resultado: Ninguno de los dos pacientes experimentó mejoría visual y ambos sufrieron afectación en el segundo ojo. Conclusiones: A pesar de casos publicados en la literatura de recuperación visual con idebenona en pacientes con NOHL, nuestra experiencia indica que este tratamiento no es efectivo para la enfermedad de Leber


Objective: To ascertain the efficacy of idebenone and multivitamin treatment in Leber’s hereditary optic neuropathy (LHON). Method: Two patients diagnosed of unilateral LHON were treated with megadoses of idebenone, vitamin C and riboflavin for one year. They were examined clinically before, during and after treatment. Results: No improvement of visual function was observed. Despite the idebenone treatment, in both cases the second eye became involved. Conclusions: Despite previous reports of visual recovery with idebenone in patients with LHON, our experience shows that an effective treatment for Leber’s disease remains to be found


Subject(s)
Male , Female , Adult , Humans , Benzoquinones/administration & dosage , Optic Nerve Diseases/diagnosis , Optic Nerve Diseases/drug therapy , Optic Atrophy, Hereditary, Leber/complications , Optic Atrophy, Hereditary, Leber/diagnosis , Optic Atrophy/complications , Optic Atrophy/diagnosis , Riboflavin/therapeutic use , Drug Therapy, Combination , Benzoquinones/therapeutic use , Optic Atrophy, Hereditary, Leber/drug therapy , Ascorbic Acid/therapeutic use , Optic Atrophy/drug therapy , Optic Atrophy/epidemiology , Optic Atrophy/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...